IMA-1

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameIMA-1
Drug Alias NameIMA-1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcetyl-CoA carboxylase 1 inhibitors +[2] 
TargetsAcetyl-CoA carboxylase 112-lipoxygenase
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesWuhan University
China Registration ClassN/A

Develop Information

Active CompaniesWuhan University
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A